Pharmacy operator Dr. Max acquires Italian group Neo Apotek
17/11/2023 16:16
MILAN, Nov 17 (Reuters) - European pharmacy operator Dr.
Max Group said on Friday it had bought Italian pharmacy network
Neo Apotek SpA, aiming to strengthen its presence in the
country.
The acquisition gives Neo Apotek Spa an enterprise value of
around 400 million euros ($435 million), a source close to the
matter told Reuters.
Dr. Max, which is controlled by Penta Investments and has
over 3,000 high street outlets and online stores in Europe, said
it would control around 210 pharmacies in Italy after adding 130
through the Neo Apotek acquisition.
Dr. Max was assisted by EY, Shearman & Sterling and AK Evan
as advisers. Neo Apotek was assisted by Rothschild & Co., Studio
Legale Gattai and Banca Profilo.
($1 = 0.9197 euros)
(Reporting by Elisa Anzolin, editing by Gavin Jones)
((elisa.anzolin@thomsonreuters.com; 0039 0266129692;))